11/14/2024 8:00 PM | Redmile Group, LLC (Filed by) Repare Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024 8:42 AM | Deep Track Capital, LP (Filed by) Repare Therapeutics (Subject)
| Form SC 13G/A | |
11/07/2024 7:33 AM | Repare Therapeutics (Filer)
| Form 424B5 | |
11/07/2024 6:10 AM | Repare Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2024 6:15 AM | Repare Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/19/2024 11:15 PM | Repare Therapeutics (Filer)
| Form EFFECT | |
08/07/2024 8:06 AM | Repare Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
08/06/2024 3:41 PM | Repare Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
08/06/2024 3:20 PM | Repare Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/20/2024 3:27 PM | Repare Therapeutics (Issuer) Stein Steven H (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
06/20/2024 3:36 PM | Repare Therapeutics (Issuer) SCHAFER CAROL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 3:35 PM | Repare Therapeutics (Issuer) Stein Steven H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 3:35 PM | Civik Thomas (Reporting) Repare Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 3:35 PM | Bonita David P (Reporting) Repare Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 3:35 PM | Kulkarni Samarth (Reporting) Repare Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 3:35 PM | Molineaux Susan (Reporting) Repare Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 3:35 PM | Morrison Briggs (Reporting) Repare Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 3:35 PM | Repare Therapeutics (Issuer) RHOADS ANN D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2024 3:06 PM | Repare Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/26/2024 3:14 PM | Repare Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/01/2024 8:27 PM | Koehler Maria (Reporting) Repare Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2024 8:28 PM | Repare Therapeutics (Issuer) Zinda Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2024 8:30 PM | Forte Steve (Reporting) Repare Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2024 8:31 PM | Repare Therapeutics (Issuer) Segal Lloyd Mitchell (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 5:54 PM | Repare Therapeutics (Issuer) Segal Lloyd Mitchell (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 5:56 PM | Koehler Maria (Reporting) Repare Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 5:57 PM | Repare Therapeutics (Issuer) Zinda Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 5:59 PM | Forte Steve (Reporting) Repare Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/27/2024 11:37 AM | Forte Steve (Reporting) Repare Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2024 1:50 PM | Repare Therapeutics (Subject) Segal Lloyd Mitchell (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/25/2024 6:25 PM | Repare Therapeutics (Subject) Segal Lloyd Mitchell (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/25/2024 3:23 PM | Koehler Maria (Reporting) Repare Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/25/2024 3:23 PM | Repare Therapeutics (Subject) Zinda Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 8:02 PM | Koehler Maria (Reporting) Repare Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 8:04 PM | Repare Therapeutics (Issuer) Segal Lloyd Mitchell (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 8:06 PM | Repare Therapeutics (Issuer) Zinda Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 6:10 AM | Repare Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/28/2024 6:15 AM | Repare Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/14/2024 8:02 PM | Blue Owl Capital Holdings LP (Filed by) Repare Therapeutics (Subject)
| Form SC 13G | |
02/14/2024 7:54 AM | Deep Track Capital, LP (Filed by) Repare Therapeutics (Subject)
| Form SC 13G/A | |
01/29/2024 3:01 PM | ARK Investment Management LLC (Filed by) Repare Therapeutics (Subject)
| Form SC 13G/A | |
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad) As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential.
Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! |
01/25/2024 1:29 PM | Repare Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/12/2024 3:05 PM | Repare Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/12/2023 3:19 PM | Koehler Maria (Reporting) Repare Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |